Autoantibodies in systemic sclerosis

S Mehra, J Walker, K Patterson, MJ Fritzler - Autoimmunity reviews, 2013 - Elsevier
Autoantibodies directed against a variety of nuclear, cytoplasmic and extracellular
autoantigens are a serological hallmark of systemic sclerosis. This review provides an …

The diagnosis and classification of undifferentiated connective tissue diseases

M Mosca, C Tani, S Vagnani, L Carli… - Journal of autoimmunity, 2014 - Elsevier
The term undifferentiated connective tissue disease (UCTD) refers to unclassifiable systemic
autoimmune diseases which share clinical and serological manifestations with definite …

Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of …

T Minier, S Guiducci, S Bellando-Randone… - Annals of the …, 2014 - ard.bmj.com
Objectives The EULAR (European League Against Rheumatism) Scleroderma Trials and
Research Group (EUSTAR) has identified preliminary criteria for very early diagnosis of …

Clinical and serological hallmarks of systemic sclerosis overlap syndromes

A Pakozdi, S Nihtyanova, PIA Moinzadeh… - The Journal of …, 2011 - jrheum.org
Objective. To determine the prevalence of systemic sclerosis (SSc) overlap syndrome and
autoantibody profile in a large single-center cohort. Methods. SSc diagnoses, subsets, and …

Interpretation of an extended autoantibody profile in a well‐characterized Australian systemic sclerosis (scleroderma) cohort using principal components analysis

KA Patterson, PJ Roberts‐Thomson… - Arthritis & …, 2015 - Wiley Online Library
Objective To determine the relationships between systemic sclerosis (SSc)–related
autoantibodies, as well as their clinical associations, in a well‐characterized Australian …

Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study

EH Park, V Strand, YJ Oh, YW Song, EB Lee - Arthritis research & therapy, 2019 - Springer
Abstract Background Systemic sclerosis (SSc) is a rare autoimmune disease characterized
by fibrosis of the skin and the involvement of multiple internal organs. Previous studies …

Therapy of scleroderma renal crisis: State of the art

E Zanatta, P Polito, M Favaro, M Larosa, P Marson… - Autoimmunity …, 2018 - Elsevier
Scleroderma renal crisis (SRC) is an uncommon but still life-threatening manifestation of
systemic sclerosis (SSc). The incidence of SRC has decreased in the last few decades …

Treatment of systemic sclerosis complications: what to use when first-line treatment fails—a consensus of systemic sclerosis experts

KM Walker, J Pope… - Seminars in arthritis and …, 2012 - Elsevier
OBJECTIVES: There is a need for standardization in systemic sclerosis (SSc) management.
METHODS: SSc experts (n= 117) were sent 3 surveys to gain consensus for SSc …

Prevalence of anti–RNA polymerase III antibodies in systemic sclerosis: new data from a French cohort and a systematic review and meta‐analysis

V Sobanski, L Dauchet, G Lefevre… - Arthritis & …, 2014 - Wiley Online Library
Objective Studies assessing the prevalence of anti–RNA polymerase III (anti–RNAP III)
antibodies in systemic sclerosis (SSc) have yielded a wide range of results. The aim of the …

Hypomethylation and overexpression of ITGAL (CD11a) in CD4+ T cells in systemic sclerosis

YY Wang, Y Shu, YF Xiao, Q Wang, T Kanekura… - Clinical …, 2014 - Springer
Background The pathogenesis and etiology of systemic sclerosis (SSc) are complex and
poorly understood. To date, several studies have demonstrated that the activation of the …